COVID-19 Impact on Global Mycosis Fungoides Therapeutics Market Size, Status and Forecast 2020-2026

August 2020 | 95 pages | ID: C627AFBD16DCEN
QYResearch

Abstracts

This report focuses on the global Mycosis Fungoides Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Mycosis Fungoides Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Azurity Pharmaceuticals Inc.
• Celgene Corp.
• Eisai Co. Ltd.
• Helsinn Healthcare SA
• Horizon Therapeutics Plc
• Kyowa Kirin Co. Ltd.
• Merck & Co. Inc.
• Seattle Genetics Inc.
• Soligenix Inc.
• Takeda Pharmaceutical Co. Ltd.

Market segment by Type, the product can be split into

• Small Molecules
• Biologics

Market segment by Application, split into

• Hospital
• Clinic
• Other

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Mycosis Fungoides Therapeutics status, future forecast, growth opportunity, key market and key players.
• To present the Mycosis Fungoides Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Mycosis Fungoides Therapeutics are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Mycosis Fungoides Therapeutics Revenue
1.4 Market Analysis by Type
  1.4.1 Global Mycosis Fungoides Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Small Molecules
  1.4.3 Biologics
1.5 Market by Application
  1.5.1 Global Mycosis Fungoides Therapeutics Market Share by Application: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Clinic
  1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Mycosis Fungoides Therapeutics Industry Impact
  1.6.1 How the Covid-19 is Affecting the Mycosis Fungoides Therapeutics Industry
    1.6.1.1 Mycosis Fungoides Therapeutics Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Mycosis Fungoides Therapeutics Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Mycosis Fungoides Therapeutics Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Mycosis Fungoides Therapeutics Market Perspective (2015-2026)
2.2 Mycosis Fungoides Therapeutics Growth Trends by Regions
  2.2.1 Mycosis Fungoides Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Mycosis Fungoides Therapeutics Historic Market Share by Regions (2015-2020)
  2.2.3 Mycosis Fungoides Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Mycosis Fungoides Therapeutics Market Growth Strategy
  2.3.6 Primary Interviews with Key Mycosis Fungoides Therapeutics Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Mycosis Fungoides Therapeutics Players by Market Size
  3.1.1 Global Top Mycosis Fungoides Therapeutics Players by Revenue (2015-2020)
  3.1.2 Global Mycosis Fungoides Therapeutics Revenue Market Share by Players (2015-2020)
  3.1.3 Global Mycosis Fungoides Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Mycosis Fungoides Therapeutics Market Concentration Ratio
  3.2.1 Global Mycosis Fungoides Therapeutics Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Mycosis Fungoides Therapeutics Revenue in 2019
3.3 Mycosis Fungoides Therapeutics Key Players Head office and Area Served
3.4 Key Players Mycosis Fungoides Therapeutics Product Solution and Service
3.5 Date of Enter into Mycosis Fungoides Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Mycosis Fungoides Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Mycosis Fungoides Therapeutics Forecasted Market Size by Type (2021-2026)

5 MYCOSIS FUNGOIDES THERAPEUTICS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Mycosis Fungoides Therapeutics Market Size by Application (2015-2020)
5.2 Global Mycosis Fungoides Therapeutics Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Mycosis Fungoides Therapeutics Market Size (2015-2020)
6.2 Mycosis Fungoides Therapeutics Key Players in North America (2019-2020)
6.3 North America Mycosis Fungoides Therapeutics Market Size by Type (2015-2020)
6.4 North America Mycosis Fungoides Therapeutics Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Mycosis Fungoides Therapeutics Market Size (2015-2020)
7.2 Mycosis Fungoides Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Mycosis Fungoides Therapeutics Market Size by Type (2015-2020)
7.4 Europe Mycosis Fungoides Therapeutics Market Size by Application (2015-2020)

8 CHINA

8.1 China Mycosis Fungoides Therapeutics Market Size (2015-2020)
8.2 Mycosis Fungoides Therapeutics Key Players in China (2019-2020)
8.3 China Mycosis Fungoides Therapeutics Market Size by Type (2015-2020)
8.4 China Mycosis Fungoides Therapeutics Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Mycosis Fungoides Therapeutics Market Size (2015-2020)
9.2 Mycosis Fungoides Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Mycosis Fungoides Therapeutics Market Size by Type (2015-2020)
9.4 Japan Mycosis Fungoides Therapeutics Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Mycosis Fungoides Therapeutics Market Size (2015-2020)
10.2 Mycosis Fungoides Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Mycosis Fungoides Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Mycosis Fungoides Therapeutics Market Size by Application (2015-2020)

11 INDIA

11.1 India Mycosis Fungoides Therapeutics Market Size (2015-2020)
11.2 Mycosis Fungoides Therapeutics Key Players in India (2019-2020)
11.3 India Mycosis Fungoides Therapeutics Market Size by Type (2015-2020)
11.4 India Mycosis Fungoides Therapeutics Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Mycosis Fungoides Therapeutics Market Size (2015-2020)
12.2 Mycosis Fungoides Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Mycosis Fungoides Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Mycosis Fungoides Therapeutics Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Azurity Pharmaceuticals Inc.
  13.1.1 Azurity Pharmaceuticals Inc. Company Details
  13.1.2 Azurity Pharmaceuticals Inc. Business Overview and Its Total Revenue
  13.1.3 Azurity Pharmaceuticals Inc. Mycosis Fungoides Therapeutics Introduction
  13.1.4 Azurity Pharmaceuticals Inc. Revenue in Mycosis Fungoides Therapeutics Business (2015-2020))
  13.1.5 Azurity Pharmaceuticals Inc. Recent Development
13.2 Celgene Corp.
  13.2.1 Celgene Corp. Company Details
  13.2.2 Celgene Corp. Business Overview and Its Total Revenue
  13.2.3 Celgene Corp. Mycosis Fungoides Therapeutics Introduction
  13.2.4 Celgene Corp. Revenue in Mycosis Fungoides Therapeutics Business (2015-2020)
  13.2.5 Celgene Corp. Recent Development
13.3 Eisai Co. Ltd.
  13.3.1 Eisai Co. Ltd. Company Details
  13.3.2 Eisai Co. Ltd. Business Overview and Its Total Revenue
  13.3.3 Eisai Co. Ltd. Mycosis Fungoides Therapeutics Introduction
  13.3.4 Eisai Co. Ltd. Revenue in Mycosis Fungoides Therapeutics Business (2015-2020)
  13.3.5 Eisai Co. Ltd. Recent Development
13.4 Helsinn Healthcare SA
  13.4.1 Helsinn Healthcare SA Company Details
  13.4.2 Helsinn Healthcare SA Business Overview and Its Total Revenue
  13.4.3 Helsinn Healthcare SA Mycosis Fungoides Therapeutics Introduction
  13.4.4 Helsinn Healthcare SA Revenue in Mycosis Fungoides Therapeutics Business (2015-2020)
  13.4.5 Helsinn Healthcare SA Recent Development
13.5 Horizon Therapeutics Plc
  13.5.1 Horizon Therapeutics Plc Company Details
  13.5.2 Horizon Therapeutics Plc Business Overview and Its Total Revenue
  13.5.3 Horizon Therapeutics Plc Mycosis Fungoides Therapeutics Introduction
  13.5.4 Horizon Therapeutics Plc Revenue in Mycosis Fungoides Therapeutics Business (2015-2020)
  13.5.5 Horizon Therapeutics Plc Recent Development
13.6 Kyowa Kirin Co. Ltd.
  13.6.1 Kyowa Kirin Co. Ltd. Company Details
  13.6.2 Kyowa Kirin Co. Ltd. Business Overview and Its Total Revenue
  13.6.3 Kyowa Kirin Co. Ltd. Mycosis Fungoides Therapeutics Introduction
  13.6.4 Kyowa Kirin Co. Ltd. Revenue in Mycosis Fungoides Therapeutics Business (2015-2020)
  13.6.5 Kyowa Kirin Co. Ltd. Recent Development
13.7 Merck & Co. Inc.
  13.7.1 Merck & Co. Inc. Company Details
  13.7.2 Merck & Co. Inc. Business Overview and Its Total Revenue
  13.7.3 Merck & Co. Inc. Mycosis Fungoides Therapeutics Introduction
  13.7.4 Merck & Co. Inc. Revenue in Mycosis Fungoides Therapeutics Business (2015-2020)
  13.7.5 Merck & Co. Inc. Recent Development
13.8 Seattle Genetics Inc.
  13.8.1 Seattle Genetics Inc. Company Details
  13.8.2 Seattle Genetics Inc. Business Overview and Its Total Revenue
  13.8.3 Seattle Genetics Inc. Mycosis Fungoides Therapeutics Introduction
  13.8.4 Seattle Genetics Inc. Revenue in Mycosis Fungoides Therapeutics Business (2015-2020)
  13.8.5 Seattle Genetics Inc. Recent Development
13.9 Soligenix Inc.
  13.9.1 Soligenix Inc. Company Details
  13.9.2 Soligenix Inc. Business Overview and Its Total Revenue
  13.9.3 Soligenix Inc. Mycosis Fungoides Therapeutics Introduction
  13.9.4 Soligenix Inc. Revenue in Mycosis Fungoides Therapeutics Business (2015-2020)
  13.9.5 Soligenix Inc. Recent Development
13.10 Takeda Pharmaceutical Co. Ltd.
  13.10.1 Takeda Pharmaceutical Co. Ltd. Company Details
  13.10.2 Takeda Pharmaceutical Co. Ltd. Business Overview and Its Total Revenue
  13.10.3 Takeda Pharmaceutical Co. Ltd. Mycosis Fungoides Therapeutics Introduction
  13.10.4 Takeda Pharmaceutical Co. Ltd. Revenue in Mycosis Fungoides Therapeutics Business (2015-2020)
  13.10.5 Takeda Pharmaceutical Co. Ltd. Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Mycosis Fungoides Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Mycosis Fungoides Therapeutics Revenue
Table 3. Ranking of Global Top Mycosis Fungoides Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Mycosis Fungoides Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Small Molecules
Table 6. Key Players of Biologics
Table 7. COVID-19 Impact Global Market: (Four Mycosis Fungoides Therapeutics Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Mycosis Fungoides Therapeutics Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Mycosis Fungoides Therapeutics Players to Combat Covid-19 Impact
Table 12. Global Mycosis Fungoides Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Mycosis Fungoides Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Mycosis Fungoides Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Mycosis Fungoides Therapeutics Market Share by Regions (2015-2020)
Table 16. Global Mycosis Fungoides Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Mycosis Fungoides Therapeutics Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Mycosis Fungoides Therapeutics Market Growth Strategy
Table 22. Main Points Interviewed from Key Mycosis Fungoides Therapeutics Players
Table 23. Global Mycosis Fungoides Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 24. Global Mycosis Fungoides Therapeutics Market Share by Players (2015-2020)
Table 25. Global Top Mycosis Fungoides Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mycosis Fungoides Therapeutics as of 2019)
Table 26. Global Mycosis Fungoides Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Mycosis Fungoides Therapeutics Product Solution and Service
Table 29. Date of Enter into Mycosis Fungoides Therapeutics Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Mycosis Fungoides Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 32. Global Mycosis Fungoides Therapeutics Market Size Share by Type (2015-2020)
Table 33. Global Mycosis Fungoides Therapeutics Revenue Market Share by Type (2021-2026)
Table 34. Global Mycosis Fungoides Therapeutics Market Size Share by Application (2015-2020)
Table 35. Global Mycosis Fungoides Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 36. Global Mycosis Fungoides Therapeutics Market Size Share by Application (2021-2026)
Table 37. North America Key Players Mycosis Fungoides Therapeutics Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Mycosis Fungoides Therapeutics Market Share (2019-2020)
Table 39. North America Mycosis Fungoides Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 40. North America Mycosis Fungoides Therapeutics Market Share by Type (2015-2020)
Table 41. North America Mycosis Fungoides Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 42. North America Mycosis Fungoides Therapeutics Market Share by Application (2015-2020)
Table 43. Europe Key Players Mycosis Fungoides Therapeutics Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Mycosis Fungoides Therapeutics Market Share (2019-2020)
Table 45. Europe Mycosis Fungoides Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Mycosis Fungoides Therapeutics Market Share by Type (2015-2020)
Table 47. Europe Mycosis Fungoides Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Mycosis Fungoides Therapeutics Market Share by Application (2015-2020)
Table 49. China Key Players Mycosis Fungoides Therapeutics Revenue (2019-2020) (Million US$)
Table 50. China Key Players Mycosis Fungoides Therapeutics Market Share (2019-2020)
Table 51. China Mycosis Fungoides Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 52. China Mycosis Fungoides Therapeutics Market Share by Type (2015-2020)
Table 53. China Mycosis Fungoides Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 54. China Mycosis Fungoides Therapeutics Market Share by Application (2015-2020)
Table 55. Japan Key Players Mycosis Fungoides Therapeutics Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Mycosis Fungoides Therapeutics Market Share (2019-2020)
Table 57. Japan Mycosis Fungoides Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Mycosis Fungoides Therapeutics Market Share by Type (2015-2020)
Table 59. Japan Mycosis Fungoides Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Mycosis Fungoides Therapeutics Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Mycosis Fungoides Therapeutics Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Mycosis Fungoides Therapeutics Market Share (2019-2020)
Table 63. Southeast Asia Mycosis Fungoides Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Mycosis Fungoides Therapeutics Market Share by Type (2015-2020)
Table 65. Southeast Asia Mycosis Fungoides Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Mycosis Fungoides Therapeutics Market Share by Application (2015-2020)
Table 67. India Key Players Mycosis Fungoides Therapeutics Revenue (2019-2020) (Million US$)
Table 68. India Key Players Mycosis Fungoides Therapeutics Market Share (2019-2020)
Table 69. India Mycosis Fungoides Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 70. India Mycosis Fungoides Therapeutics Market Share by Type (2015-2020)
Table 71. India Mycosis Fungoides Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 72. India Mycosis Fungoides Therapeutics Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Mycosis Fungoides Therapeutics Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Mycosis Fungoides Therapeutics Market Share (2019-2020)
Table 75. Central & South America Mycosis Fungoides Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Mycosis Fungoides Therapeutics Market Share by Type (2015-2020)
Table 77. Central & South America Mycosis Fungoides Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Mycosis Fungoides Therapeutics Market Share by Application (2015-2020)
Table 79. Azurity Pharmaceuticals Inc. Company Details
Table 80. Azurity Pharmaceuticals Inc. Business Overview
Table 81. Azurity Pharmaceuticals Inc. Product
Table 82. Azurity Pharmaceuticals Inc. Revenue in Mycosis Fungoides Therapeutics Business (2015-2020) (Million US$)
Table 83. Azurity Pharmaceuticals Inc. Recent Development
Table 84. Celgene Corp. Company Details
Table 85. Celgene Corp. Business Overview
Table 86. Celgene Corp. Product
Table 87. Celgene Corp. Revenue in Mycosis Fungoides Therapeutics Business (2015-2020) (Million US$)
Table 88. Celgene Corp. Recent Development
Table 89. Eisai Co. Ltd. Company Details
Table 90. Eisai Co. Ltd. Business Overview
Table 91. Eisai Co. Ltd. Product
Table 92. Eisai Co. Ltd. Revenue in Mycosis Fungoides Therapeutics Business (2015-2020) (Million US$)
Table 93. Eisai Co. Ltd. Recent Development
Table 94. Helsinn Healthcare SA Company Details
Table 95. Helsinn Healthcare SA Business Overview
Table 96. Helsinn Healthcare SA Product
Table 97. Helsinn Healthcare SA Revenue in Mycosis Fungoides Therapeutics Business (2015-2020) (Million US$)
Table 98. Helsinn Healthcare SA Recent Development
Table 99. Horizon Therapeutics Plc Company Details
Table 100. Horizon Therapeutics Plc Business Overview
Table 101. Horizon Therapeutics Plc Product
Table 102. Horizon Therapeutics Plc Revenue in Mycosis Fungoides Therapeutics Business (2015-2020) (Million US$)
Table 103. Horizon Therapeutics Plc Recent Development
Table 104. Kyowa Kirin Co. Ltd. Company Details
Table 105. Kyowa Kirin Co. Ltd. Business Overview
Table 106. Kyowa Kirin Co. Ltd. Product
Table 107. Kyowa Kirin Co. Ltd. Revenue in Mycosis Fungoides Therapeutics Business (2015-2020) (Million US$)
Table 108. Kyowa Kirin Co. Ltd. Recent Development
Table 109. Merck & Co. Inc. Company Details
Table 110. Merck & Co. Inc. Business Overview
Table 111. Merck & Co. Inc. Product
Table 112. Merck & Co. Inc. Revenue in Mycosis Fungoides Therapeutics Business (2015-2020) (Million US$)
Table 113. Merck & Co. Inc. Recent Development
Table 114. Seattle Genetics Inc. Business Overview
Table 115. Seattle Genetics Inc. Product
Table 116. Seattle Genetics Inc. Company Details
Table 117. Seattle Genetics Inc. Revenue in Mycosis Fungoides Therapeutics Business (2015-2020) (Million US$)
Table 118. Seattle Genetics Inc. Recent Development
Table 119. Soligenix Inc. Company Details
Table 120. Soligenix Inc. Business Overview
Table 121. Soligenix Inc. Product
Table 122. Soligenix Inc. Revenue in Mycosis Fungoides Therapeutics Business (2015-2020) (Million US$)
Table 123. Soligenix Inc. Recent Development
Table 124. Takeda Pharmaceutical Co. Ltd. Company Details
Table 125. Takeda Pharmaceutical Co. Ltd. Business Overview
Table 126. Takeda Pharmaceutical Co. Ltd. Product
Table 127. Takeda Pharmaceutical Co. Ltd. Revenue in Mycosis Fungoides Therapeutics Business (2015-2020) (Million US$)
Table 128. Takeda Pharmaceutical Co. Ltd. Recent Development
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Mycosis Fungoides Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Small Molecules Features
Figure 3. Biologics Features
Figure 4. Global Mycosis Fungoides Therapeutics Market Share by Application: 2020 VS 2026
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Other Case Studies
Figure 8. Mycosis Fungoides Therapeutics Report Years Considered
Figure 9. Global Mycosis Fungoides Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Mycosis Fungoides Therapeutics Market Share by Regions: 2020 VS 2026
Figure 11. Global Mycosis Fungoides Therapeutics Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Mycosis Fungoides Therapeutics Market Share by Players in 2019
Figure 14. Global Top Mycosis Fungoides Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mycosis Fungoides Therapeutics as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Mycosis Fungoides Therapeutics Revenue in 2019
Figure 16. North America Mycosis Fungoides Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Mycosis Fungoides Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Mycosis Fungoides Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Mycosis Fungoides Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Mycosis Fungoides Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Mycosis Fungoides Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Mycosis Fungoides Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Azurity Pharmaceuticals Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Azurity Pharmaceuticals Inc. Revenue Growth Rate in Mycosis Fungoides Therapeutics Business (2015-2020)
Figure 25. Celgene Corp. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Celgene Corp. Revenue Growth Rate in Mycosis Fungoides Therapeutics Business (2015-2020)
Figure 27. Eisai Co. Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Eisai Co. Ltd. Revenue Growth Rate in Mycosis Fungoides Therapeutics Business (2015-2020)
Figure 29. Helsinn Healthcare SA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Helsinn Healthcare SA Revenue Growth Rate in Mycosis Fungoides Therapeutics Business (2015-2020)
Figure 31. Horizon Therapeutics Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Horizon Therapeutics Plc Revenue Growth Rate in Mycosis Fungoides Therapeutics Business (2015-2020)
Figure 33. Kyowa Kirin Co. Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Kyowa Kirin Co. Ltd. Revenue Growth Rate in Mycosis Fungoides Therapeutics Business (2015-2020)
Figure 35. Merck & Co. Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Merck & Co. Inc. Revenue Growth Rate in Mycosis Fungoides Therapeutics Business (2015-2020)
Figure 37. Seattle Genetics Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Seattle Genetics Inc. Revenue Growth Rate in Mycosis Fungoides Therapeutics Business (2015-2020)
Figure 39. Soligenix Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Soligenix Inc. Revenue Growth Rate in Mycosis Fungoides Therapeutics Business (2015-2020)
Figure 41. Takeda Pharmaceutical Co. Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Takeda Pharmaceutical Co. Ltd. Revenue Growth Rate in Mycosis Fungoides Therapeutics Business (2015-2020)
Figure 43. Bottom-up and Top-down Approaches for This Report
Figure 44. Data Triangulation
Figure 45. Key Executives Interviewed